TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia. See ...

The U.S. Agency for International Development (USAID) not only disbursed $44 billion in fiscal 2023, but anchors private ...

The United States' decision to freeze and potentially scrap its core aid agency jolted countries receiving its funding and ...